PGM1-CDGG

Silvia Radenkovic1, Sofie Bleukx2, Nicole Engelhardt3

  • 1Department of Clinical Genomics, Mayo Clinic, Rochester, MN, USA; Department of Genetics, Section Metabolic Diagnostics, UMC Utrecht, Utrecht, NL.

概括

凝血异常常见于糖突变酶-1-血糖化 (PGM1-CDG) 的先天性障碍,并且在治疗D-银糖时得到改善. 抗血素缺乏症很常见,而D-银糖在治疗这些PGM1-CDG并发症方面表现有前途.

相关概念视频

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
824
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
672